Oleg Kovtun
Last active: 3/22/2022

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. A Novel Biotinylated Homotryptamine Derivative for Quantum Dot Imaging of Serotonin Transporter in Live Cells. Tomlinson ID, Kovtun O, Torres R, Bellocchio LG, Josephs T, Rosenthal SJ (2021) Front Cell Neurosci : 667044
    › Primary publication · 34867196 (PubMed) · PMC8637195 (PubMed Central)
  2. Membrane Nanoscopic Organization of D2L Dopamine Receptor Probed by Quantum Dot Tracking. Kovtun O, Torres R, Bellocchio LG, Rosenthal SJ (2021) Membranes (Basel) 11(8)
    › Primary publication · 34436341 (PubMed) · PMC8401772 (PubMed Central)
  3. Correction: Enlightened: addressing circadian and seasonal changes in photoperiod in animal models of bipolar disorder. McCarty R, Josephs T, Kovtun O, Rosenthal SJ (2021) Transl Psychiatry 11(1): 400
    › Primary publication · 34290224 (PubMed) · PMC8295380 (PubMed Central)
  4. Enlightened: addressing circadian and seasonal changes in photoperiod in animal models of bipolar disorder. McCarty R, Josephs T, Kovtun O, Rosenthal SJ (2021) Transl Psychiatry 11(1): 373
    › Primary publication · 34226504 (PubMed) · PMC8257630 (PubMed Central)
  5. Rate of change in solar insolation is a hidden variable that influences seasonal alterations in bipolar disorder. Rosenthal SJ, Josephs T, Kovtun O, McCarty R (2021) Brain Behav 11(7): e02198
    › Primary publication · 34061463 (PubMed) · PMC8323043 (PubMed Central)
  6. Single Quantum Dot Tracking Unravels Agonist Effects on the Dopamine Receptor Dynamics. Kovtun O, Torres R, Ferguson RS, Josephs T, Rosenthal SJ (2021) Biochemistry 60(13): 1031-1043
    › Primary publication · 32584548 (PubMed)
  7. Seasonal effects on bipolar disorder: A closer look. Rosenthal SJ, Josephs T, Kovtun O, McCarty R (2020) Neurosci Biobehav Rev : 199-219
    › Primary publication · 32485266 (PubMed)
  8. Labeling Neuronal Proteins with Quantum Dots for Single-Molecule Imaging. Thal LB, Kovtun O, Rosenthal SJ (2020) Methods Mol Biol : 169-177
    › Primary publication · 32246334 (PubMed)
  9. Quantitative Analysis of Single Quantum Dot Trajectories. Kovtun O, Thal LB, Josephs T, Rosenthal SJ (2020) Methods Mol Biol : 109-123
    › Primary publication · 32246331 (PubMed)
  10. Quantum dots reveal heterogeneous membrane diffusivity and dynamic surface density polarization of dopamine transporter. Kovtun O, Tomlinson ID, Ferguson RS, Rosenthal SJ (2019) PLoS One 14(11): e0225339
    › Primary publication · 31751387 (PubMed) · PMC6872175 (PubMed Central)
  11. Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures. Tomlinson ID, Kovtun O, Crescentini TM, Rosenthal SJ (2019) Bioorg Med Chem Lett 29(8): 959-964
    › Primary publication · 30808590 (PubMed)
  12. Single Quantum Dot Tracking Illuminates Neuroscience at the Nanoscale. Kovtun O, Tomlinson ID, Bailey DM, Thal LB, Ross EJ, Harris L, Frankland MP, Ferguson RS, Glaser Z, Greer J, Rosenthal SJ (2018) Chem Phys Lett : 741-752
    › Primary publication · 30270931 (PubMed) · PMC6157616 (PubMed Central)
  13. Single Quantum Dot Imaging Reveals PKCĪ²-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant. Thal LB, Tomlinson ID, Quinlan MA, Kovtun O, Blakely RD, Rosenthal SJ (2019) ACS Chem Neurosci 10(1): 460-471
    › Primary publication · 30153408 (PubMed) · PMC6411462 (PubMed Central)
  14. Single Quantum Dot Tracking Reveals Serotonin Transporter Diffusion Dynamics are Correlated with Cholesterol-Sensitive Threonine 276 Phosphorylation Status in Primary Midbrain Neurons. Bailey DM, Catron MA, Kovtun O, Macdonald RL, Zhang Q, Rosenthal SJ (2018) ACS Chem Neurosci 9(11): 2534-2541
    › Primary publication · 29787674 (PubMed)
  15. Antibody-Conjugated Single Quantum Dot Tracking of Membrane Neurotransmitter Transporters in Primary Neuronal Cultures. Bailey DM, Kovtun O, Rosenthal SJ (2017) Methods Mol Biol : 165-177
    › Primary publication · 28238136 (PubMed)
  16. Single-quantum-dot tracking reveals altered membrane dynamics of an attention-deficit/hyperactivity-disorder-derived dopamine transporter coding variant. Kovtun O, Sakrikar D, Tomlinson ID, Chang JC, Arzeta-Ferrer X, Blakely RD, Rosenthal SJ (2015) ACS Chem Neurosci 6(4): 526-34
    › Primary publication · 25747272 (PubMed) · PMC5530757 (PubMed Central)
  17. Quantum dot approaches for target-based drug screening and multiplexed active biosensing. Kovtun O, Arzeta-Ferrer X, Rosenthal SJ (2013) Nanoscale 5(24): 12072-81
    › Primary publication · 23946011 (PubMed)
  18. Labeling of neuronal receptors and transporters with quantum dots. Chang JC, Kovtun O, Blakely RD, Rosenthal SJ (2012) Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(6): 605-19
    › Primary publication · 22887823 (PubMed) · PMC3753009 (PubMed Central)
  19. Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. Kovtun O, Tomlinson ID, Sakrikar DS, Chang JC, Blakely RD, Rosenthal SJ (2011) ACS Chem Neurosci 2(7): 370-8
    › Primary publication · 22816024 (PubMed) · PMC3369746 (PubMed Central)
  20. A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots. Kovtun O, Ross EJ, Tomlinson ID, Rosenthal SJ (2012) Chem Commun (Camb) 48(44): 5428-30
    › Primary publication · 22543630 (PubMed)
  21. Biocompatible quantum dots for biological applications. Rosenthal SJ, Chang JC, Kovtun O, McBride JR, Tomlinson ID (2011) Chem Biol 18(1): 10-24
    › Primary publication · 21276935 (PubMed) · PMC3752999 (PubMed Central)